We are live on ! Find out more
ALIM

Alimera Sciences
ALIM

Delisted

ALIM was delisted on the 13th of September, 2024.

Back to rankings

37 hedge funds and large institutions have $35.5M invested in Alimera Sciences in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

1% less capital invested

Capital invested by funds: $35.8M → $35.5M (-$278K)

8% less funds holding

Funds holding: 40 → 37 (-3)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Holders
37
Holders Change
-3
Holders Change %
-7.5%
% of All Funds
0.85%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
8
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.06M
2
SCM
Stonepine Capital Management
Oregon
+$751K
3
Renaissance Technologies
Renaissance Technologies
New York
+$92.8K
4
BlackRock
BlackRock
New York
+$56.6K
5
DMK
David M. Knott
+$34.7K

Top Sellers

Rank Fund Capital Flow
1
JAM
JW Asset Management
Florida
-$265K
2
BCM
Bridgeway Capital Management
Texas
-$93.7K
3
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$75K
4
ARTA
A.R.T. Advisors
New York
-$43K
5
Citadel Advisors
Citadel Advisors
Florida
-$42K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Stonepine Capital Management
Oregon
$6.83M +$751K +53,410 +13%
AC
2
Armistice Capital
New York
$6.79M – – –
ACA
3
Avoro Capital Advisors
New York
$6.11M – – –
DM
4
Deerfield Management
New York
$5.92M – – –
PAI
5
Palo Alto Investors
California
$2.95M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.04M -$17K -1,207 -0.9%
Morgan Stanley
7
Morgan Stanley
New York
$1.11M +$1.06M +75,461 +279,485%
ACP
8
Acuta Capital Partners
California
$953K – – –
Renaissance Technologies
9
Renaissance Technologies
New York
$562K +$92.8K +6,600 +21%
BCM
10
Bridgeway Capital Management
Texas
$479K -$93.7K -6,667 -17%
JAM
11
JW Asset Management
Florida
$404K -$265K -18,847 -41%
BlackRock
12
BlackRock
New York
$266K +$56.6K +4,022 +28%
DMK
13
David M. Knott
$259K +$34.7K +2,467 +16%
O
14
OrbiMed
New York
$245K – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$141K – – –
Northern Trust
16
Northern Trust
Illinois
$109K – – –
WMSA
17
Weiss Multi-Strategy Advisers
New York
$82K +$6.68K +475 +9%
SO
18
STRS Ohio
Ohio
$42K – – –
SIM
19
Spark Investment Management
New York
$41K +$9K +640 +29%
SCM
20
Southport Capital Management
Tennessee
$31K -$98 -7 -0.3%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$27K -$8.04K -572 -24%
Cambridge Investment Research Advisors
22
Cambridge Investment Research Advisors
Iowa
$23K – – –
Goldman Sachs
23
Goldman Sachs
New York
$21K +$1.01K +72 +5%
BFM
24
Boothbay Fund Management
New York
$19K +$18.2K +1,295 New
MCM
25
Mainstay Capital Management
Michigan
$15K – – –
1
2

ALIM Hedge Fund Activity: Q2 2018 in Review

37 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q2 2018, worth a combined $35.5M — down 0.78% from $35.8M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ALIM and 5 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 8 added.

The largest buyer was Morgan Stanley, adding an estimated $1.06M. The largest seller was JW Asset Management, cutting an estimated $265K.

  • 37 institutional investors held Alimera Sciences (ALIM) as of Q2 2018, down from 40 in Q1 2018.
  • Funds reported $35.5M of Alimera Sciences stock for Q2 2018, down 0.78% quarter-over-quarter.
  • 5 funds opened new Alimera Sciences positions in Q2 2018 and 8 closed out, a net change of -3 holders.
  • The largest Alimera Sciences buyer in Q2 2018 was Morgan Stanley, an estimated $1.06M added.
  • The largest Alimera Sciences seller in Q2 2018 was JW Asset Management, an estimated $265K sold.

Based on aggregated 13F filings for Q2 2018.